Skip to main content

Mobilising the European nano-biomedical ecosystem

Objective

In order to compete globally, Europe has to innovate and develop nanomedicines and medical technologies with high value and high technological content, well protected IP, and ensuring both a clinical need and commercial opportunities of all new innovations. Technically, this will be achieved by combining elements of key enabling technologies like nanotechnologies, photonics, robotics, advanced materials and information technologies to get smart medical devices and smart nanomedicines. However, the translation of the preclinical proof of concepts to the market via clinical validation, regulatory approval, and approval for reimbursement by the healthcare systems, requires a more integrated and streamlined ecosystem with less barriers between stakeholders and steps. Following their successful experience in the past 12 years of development in nanomedicine and medical technologies, ETPN and the seven other partners of NOBEL are merging their networks to set up a coherent, robust and unique ecosystem where information flow will improve awareness all along the value chain right up to the market access. It develops interactions, cooperation and implementation of complementary actions at local, regional, national, European and even international levels. The building of this ecosystem is based on two main pillars: a joint vision of the strategy for the future (roadmapping) and a high cohesion and interrelationship among the members of the ecosystem. One of the most significant and impactful outputs of this inclusive efficient ecosystem is the tangible acceleration of the development and industrialization of innovative SMEs in nanomedicine and medical technologies. This will impact the renaissance of EU economy by creating jobs and value in Europe. NOBEL will be unique in building the most efficient network of connections and synergies all along the value chain of Nanomedicine and healthcare technologies in Europe.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/medical biotechnology/nanomedicine

Call for proposal

H2020-NMBP-CSA-2017
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

ETPN ASSOCIATION
Address
10 Rue Vauquelin
75005 Paris
France
Activity type
Other
EU contribution
€ 522 062

Participants (7)

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France
EU contribution
€ 287 500
Address
Rue Leblanc 25
75015 Paris 15
Activity type
Research Organisations
MEDTECH EUROPE
Belgium
EU contribution
€ 107 500
Address
40 Rue Joseph Ii
1000 Brussels
Activity type
Other
GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV
Germany
EU contribution
€ 201 250
Address
Mendelstrasse 11
48149 Munster
Activity type
Research Organisations
VDI/VDE INNOVATION + TECHNIK GMBH
Germany
EU contribution
€ 268 125
Address
Steinplatz 1
10623 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO
Portugal
EU contribution
€ 415 862
Address
Campus De Azurem Universidade Do Minho
4800 058 Guimaraes
Activity type
Other
FONDAZIONE DON CARLO GNOCCHI ONLUS
Italy
EU contribution
€ 69 250
Address
Piazzale Rodolfo Morandi 6
20148 Milano
Activity type
Research Organisations
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Ireland
EU contribution
€ 127 500
Address
Western Road
T12 YN60 Cork
Activity type
Higher or Secondary Education Establishments